|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Your results on : Equity | Company Profile | Detailed Quotes |
|
|
|
|
|
|
|
|
|
|
|
| Stock Price Details |
|
Chart |
|
| Last Price |
2,689.55 |
|
| Change |
107.65 (4.17%) |
|
| Best Buy |
0(x0) |
|
| Best Sell |
0(x0) |
|
| Today's Range |
2,569.00
- 2,698.00 |
|
| 52-Week Range |
794.00
- 2,699.00 |
|
|
|
1 Day
| 5 Day
| 3 Month
| 1 Year
| 5 Year
|
|
|
|
| News |
|
Corporate Details |
|
|
|
| Incorporation Year : 1987 |
|
| Chairman : Daulat N Medhora |
|
| Ownership Group : Indian Private |
|
| Sector : MAN |
|
| Industry : Pharmaceuticals - Indian - Formulations |
|
| Registered Office |
|
Fredun Pharmaceuticals Ltd 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, , Maharashtra-400031 |
|
Phone:91-22-40318111 Fax: |
|
| E-Mail : business@fredungroup.com |
|
| URL : http://www.fredungroup.com |
|
|
|
| Investor Returns |
|
| |
|
Date |
|
Price (Rs) |
|
Returns (%) |
|
|
| 1Week |
18-Jun-2026 |
2615.45 |
2.83 |
|
| 1Month |
25-May-2026 |
2384.10 |
12.81 |
|
| 3Month |
25-Mar-2026 |
1715.55 |
56.77 |
|
| 6Month |
26-Dec-2025 |
1704.65 |
57.78 |
|
| 1Year |
25-Jun-2025 |
819.45 |
228.21 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
|
Last Price(Rs) |
|
Change(%) |
|
52Week High(Rs) |
|
52Week Low(Rs) |
|
Market Cap(Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,518.15 |
0.33 |
4,714.50 |
3,170.25 |
152,914.73 |
|
| Ajanta Pharma Ltd |
3,177.90 |
-2.33 |
3,314.80 |
2,335.00 |
39,703.29 |
|
| Gland Pharma Ltd |
2,313.70 |
-0.52 |
2,395.00 |
1,575.00 |
38,166.72 |
|
| Rubicon Research Ltd |
1,416.45 |
1.39 |
1,468.00 |
571.00 |
23,425.64 |
|
| ERIS Lifesciences Ltd |
1,458.80 |
-0.45 |
1,887.65 |
1,237.90 |
20,214.19 |
|
|
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|